Menu
Recruiting NCT07453524

Assessing Chronic Pain Patient Preferences

No phase Interventional Chronic Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Patient questionnaire.
Who it may be relevant to
Registry conditions: Chronic Pain. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Assessing Chronic Pain Patient Preferences Regarding the Analgesic Effect Relative to the Side Effects of Analgesic Drugs

Overview

The goal of this study is to ask chronic pain patients their preferences regarding which side effects of pain medications are least acceptable in relation to their pain relief benefits. This information may help in the selection of improved treatment options in the future.

Interventions

  • Other Patient questionnaire
    Online patient questionnaire that assesses multiple aspects such as current analgesic use, side effect burden, treatment satisfaction and patient preferences.

Primary outcome measures

  • Chronic pain patient preferences of pain medications regarding pain relief relative to the side effects using numeric rating scales (adaptation of the outcome prioritization tool). [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
Secondary outcome measures (11)
  • Analgesic side effect burden measured by numeric rating scales (NRS) [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Patient pain levels in the last 24 hours and pain body location and its impact on functioning measured by the Brief Pain Inventory short form (BPI-SF). [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Overall pain levels in the past 7 days measured by a numeric rating scale. [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Overall sleep quality in the past 7 days measured by a numeric rating scale. [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Satisfaction of pain treatment will be assessed by select items from the PTSS [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Evaluating Patient characteristics [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • MacArthur Scale of Subjective Social Status assessing subjective social status [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Single Item Global Quality of Life Scale (SIG-QoL) [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Patient Health Questionnaire-4 (PHQ-4) is used to measure anxiety and depression [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • Current Opioid Misuse Measure - 9 items (COMM-9) is used to identify current aberrant opioid-related behavior in chronic pain patients on long-term opioid therapy [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]
  • PROMIS Item Bank v2.0 - Cognitive Function- Short Form 4a assesses patient-perceived cognitive deficits. [Time frame: Single measure at a time selected by the participant within the study period (up to 15 months).]

Eligibility criteria

Inclusion criteria

  • Aged over 18 years.
  • Being treated with pain medication.
  • (Chronic-)Pain for at least 3 months.
  • Capacity to understand and provide an informed consent form.

Exclusion criteria

  • Insufficient French or English language skills.
  • Epilepsy treated by an anti-epileptic.
  • Alzheimer's disease.
  • Parkinson's disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

Belgium · 1 center
  • UCLouvain/IONS — Brussels

Identifiers

NCT: NCT07453524 · QSPainRelief-PatientPref

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗